MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 62 filers reported holding MARRONE BIO INNOVATIONS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,692,000 | +3.1% | 1,458,400 | -4.0% | 0.00% | +100.0% |
Q1 2022 | $1,641,000 | +43.8% | 1,519,100 | -4.1% | 0.00% | 0.0% |
Q4 2021 | $1,141,000 | -25.5% | 1,583,800 | -6.8% | 0.00% | 0.0% |
Q3 2021 | $1,532,000 | -52.0% | 1,700,000 | -11.6% | 0.00% | -50.0% |
Q2 2021 | $3,194,000 | -21.1% | 1,924,000 | -0.7% | 0.00% | -33.3% |
Q1 2021 | $4,048,000 | +63.3% | 1,936,800 | -2.3% | 0.00% | +50.0% |
Q4 2020 | $2,479,000 | -0.2% | 1,983,200 | -2.6% | 0.00% | 0.0% |
Q3 2020 | $2,483,000 | -3.1% | 2,035,300 | -7.1% | 0.00% | 0.0% |
Q2 2020 | $2,563,000 | +39.4% | 2,190,300 | -2.7% | 0.00% | 0.0% |
Q1 2020 | $1,839,000 | -21.5% | 2,250,600 | -3.0% | 0.00% | 0.0% |
Q4 2019 | $2,344,000 | -29.3% | 2,320,600 | -1.3% | 0.00% | -33.3% |
Q3 2019 | $3,314,000 | -10.9% | 2,350,600 | -5.2% | 0.00% | 0.0% |
Q2 2019 | $3,721,000 | -7.2% | 2,480,710 | -5.3% | 0.00% | 0.0% |
Q1 2019 | $4,008,000 | +3.8% | 2,619,600 | -0.2% | 0.00% | 0.0% |
Q4 2018 | $3,860,000 | -19.7% | 2,625,600 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $4,805,000 | -0.5% | 2,625,600 | 0.0% | 0.00% | -25.0% |
Q2 2018 | $4,831,000 | -8.0% | 2,625,600 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $5,251,000 | +81.8% | 2,625,600 | 0.0% | 0.00% | +100.0% |
Q4 2017 | $2,888,000 | -5.4% | 2,625,600 | -1.1% | 0.00% | -33.3% |
Q3 2017 | $3,054,000 | -12.4% | 2,655,600 | -1.7% | 0.00% | 0.0% |
Q2 2017 | $3,487,000 | -34.3% | 2,702,870 | -0.6% | 0.00% | -40.0% |
Q1 2017 | $5,304,000 | -12.8% | 2,719,915 | -4.3% | 0.01% | -16.7% |
Q4 2016 | $6,084,000 | +21.1% | 2,843,200 | -2.7% | 0.01% | +20.0% |
Q3 2016 | $5,024,000 | +100.3% | 2,921,000 | -4.5% | 0.01% | +66.7% |
Q2 2016 | $2,508,000 | -13.3% | 3,058,700 | -4.9% | 0.00% | 0.0% |
Q1 2016 | $2,894,000 | -18.8% | 3,216,100 | -0.7% | 0.00% | -25.0% |
Q4 2015 | $3,564,000 | -47.9% | 3,240,200 | -0.1% | 0.00% | -50.0% |
Q3 2015 | $6,841,000 | +6.6% | 3,242,100 | 0.0% | 0.01% | +33.3% |
Q2 2015 | $6,419,000 | -48.8% | 3,242,100 | 0.0% | 0.01% | -50.0% |
Q1 2015 | $12,547,000 | +7.2% | 3,242,100 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $11,704,000 | +35.7% | 3,242,100 | 0.0% | 0.01% | +33.3% |
Q3 2014 | $8,624,000 | -75.6% | 3,242,100 | +6.6% | 0.01% | -76.9% |
Q2 2014 | $35,348,000 | +68.5% | 3,042,019 | +102.5% | 0.04% | +62.5% |
Q1 2014 | $20,983,000 | +195.7% | 1,501,983 | +276.3% | 0.02% | +166.7% |
Q4 2013 | $7,096,000 | -3.2% | 399,100 | -8.3% | 0.01% | -10.0% |
Q3 2013 | $7,330,000 | – | 435,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|